NAM:BSENam Securities Ltd. Analysis
Data as of 2026-03-15 - not real-time
₹94.81
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Nam Securities is trading at ₹94.81, comfortably above its 20‑day (≈₹80.18), 50‑day (≈₹81.87) and 200‑day (≈₹86.86) moving averages, and the MACD indicator is showing a bullish crossover (MACD line ≈ 1.68 vs signal ≈ ‑0.40). The RSI sits at 62, indicating continued upward momentum but still below overbought levels. However, the fundamentals are starkly out of sync: a trailing P/E of 249.5 versus an industry average of ~16.3, near‑zero profit margins, no dividend payout, and a 30‑day volatility exceeding 100% paint a picture of extreme overvaluation and earnings weakness.
The stock’s beta of 0.07 suggests minimal market‑wide risk, yet its thin trading volume (≈72 shares vs 10‑day average of 487) and a max drawdown of ~‑28.5% amplify liquidity and price‑risk concerns. In this context, while short‑term technicals look favorable, the lack of earnings growth, high valuation multiples, and elevated volatility argue for caution.
The stock’s beta of 0.07 suggests minimal market‑wide risk, yet its thin trading volume (≈72 shares vs 10‑day average of 487) and a max drawdown of ~‑28.5% amplify liquidity and price‑risk concerns. In this context, while short‑term technicals look favorable, the lack of earnings growth, high valuation multiples, and elevated volatility argue for caution.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- Technical momentum offset by extreme valuation (P/E ≈ 250)
- Very high 30‑day volatility (>100%)
- Thin trading volume raising liquidity concerns
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Potential price correction as valuation normalises
- Continued earnings weakness and zero cash flow
- Low systematic risk (beta ≈ 0.07) may temper broader market swings
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Fundamental turnaround required for sustainable upside
- Industry exposure to capital‑market cycles
- Absence of dividend income limits total return
Key Metrics & Analysis
Financial Health
Revenue Growth2.50%
Profit Margin0.53%
P/E Ratio249.5
Debt/Equity1.70
P/B Ratio4.4
Industry P/E16.4
Technical Analysis
TrendBearish
RSI62.1
Support₹68.00
Resistance₹99.90
MA 20₹80.18
MA 50₹81.87
MA 200₹86.86
MACDBullish
VolumeIncreasing
Fear & Greed Index72.88
Valuation
GradeOvervalued
TypeValue
Risk Assessment
Beta0.07
Volatility101.02%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskHigh
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.